Induction and drug development
- 16 August 2000
- journal article
- review article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 11 (3) , 185-189
- https://doi.org/10.1016/s0928-0987(00)00107-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Novel Method for Analysis of Nuclear Receptor Function at Natural Promoters: Peroxisome Proliferator-Activated Receptor Agonist Actions on aP2 Gene Expression Detected Using Branched DNA Messenger RNA QuantitationMolecular Endocrinology, 1999
- Phenobarbital, β-Naphthoflavone, Clofibrate, and Pregnenolone-16α-Carbonitrile Do Not Affect Hepatic Thyroid Hormone UDP-Glucuronosyl Transferase Activity, and Thyroid Gland Function in MiceToxicology and Applied Pharmacology, 1999
- Clinical Pharmacokinetics of TroglitazoneClinical Pharmacokinetics, 1999
- A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 genein vitroXenobiotica, 1999
- RosiglitazoneDrugs, 1999
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.Journal of Clinical Investigation, 1998
- RitonavirClinical Pharmacokinetics, 1998
- Human cytochrome P450s: selectivity and measurement in vivoXenobiotica, 1998
- Mechanistic Data and Risk Assessment of Selected Toxic End Points of the Thyroid GlandToxicologic Pathology, 1997
- Pharamacoepidemiological Study on Adverse Reactions of Antiepileptic Drugs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992